22 Nov (NucNet): Areva Med, a subsidiary of Areva specialising in the development of cancer treatment methods, has inaugurated a facility for the production of the lead-212 (Pb-212) isotope for medical use.
…
Areva Med Opens Facility For Lead-212 Production
Source: NucNet
Archived news summary. This item reflects its original publication date. Follow the source link below for the publisher’s full article.
Questions about this archived item? Contact Nuclear Street.